Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Brazil Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20071
20081
20091
20101
20124
20132
20141
20151
20171
20184
20195
20201
20212
20223
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting9
Recruiting4
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Bayer5
Hospital Sirio-Libanes4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Daiichi Sankyo2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
University of Sao Paulo2
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular38
Liver Neoplasms10
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Carcinoma2
Carcinoma, Renal Cell2
Carcinoma, Transitional Cell2
Colorectal Neoplasms2
Melanoma2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.